Copan Colibrí™ Receives Third FDA Clearance, Further Expanding Automated ID/AST Workup Capabilities
![](https://www.copanusa.com/wp-content/uploads/2021/06/Overview_22-1024x341.jpg)
![](https://www.copanusa.com/wp-content/uploads/2021/04/iStock-1279773766-1170x780-1-640x427.jpg)
COPAN UniVerse™ Facilitates Newly Announced Streamlined Approach for Pooled Serial Screening Testing Programs
April 21, 2021
![](https://www.copanusa.com/wp-content/uploads/2024/01/universe.jpg)
COPAN Diagnostics’ Announces its North American Launch of UniVerse™, COPAN’s Fully Automated Instrument for Molecular Specimen Preparation prior to Testing
April 19, 2021
![](https://www.copanusa.com/wp-content/uploads/2021/01/Produzione_UTM_Copan_3-500x333-1.jpeg)
COPAN Group’s Response to the Pandemic and our Efforts to Fight COVID-19 Worldwide
January 29, 2021
![](https://www.copanusa.com/wp-content/uploads/2020/10/Unknown-500x431-1.jpeg)
COPAN Remembers Daniele Triva, Inventor of Flocked Swabs for Collection and Transfer of Biological Samples
October 31, 2020
![](https://www.copanusa.com/wp-content/uploads/2020/10/CA-UTM-500x500-1.jpg)
COPAN Diagnostics Hits the 5 Million Mark on COVID-19 Sample Collection Transport Media Shipped From New Carlsbad Facility
October 22, 2020